首页 > 最新文献

SAGE Open Medicine最新文献

英文 中文
A regression predictive model for QuantiFERON-TB Gold Plus® indeterminate results in immunosuppressed patients. 免疫抑制患者 QuantiFERON-TB Gold Plus® 不确定结果的回归预测模型。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-09 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241279116
Rahma Bellagha, Tarak Dhaouadi, Awatef Riahi, Wahiba Ben Rehouma, Hajer Jedidi, Leila Mouelhi, Leila Abdelmoula, Taïeb Ben Abdallah, Yousr Gorgi, Imen Sfar

Background: Screening for latent tuberculosis infection using Interferon-Gamma Release Assays is a routine procedure prior to the initiation of anti-tumor necrosis factor (TNF) biotherapy or immunosuppressive therapy. However, indeterminate results are relatively frequent and are an obstacle to treatment initiation.

Aim: The aim of this cross-sectional study was to estimate the frequency of indeterminate QuantiFERON-TB Gold Plus® test results in Tunisian patients, and to analyze the potential clinico-biological risk factors associated with these indeterminate results.

Methods: Whole blood samples from 712 patients being monitored for autoimmune diseases and candidates for anti-TNF biotherapy or switch of immunosuppressive therapy were used to screen for latent tuberculosis infection using the QuantiFERON-TB Gold Plus® test. Based on literature background, the following variables were tested for the association with indeterminate results: gender, age, diabetes, immunosuppressive drugs, lymphocyte count, Neutrophil-to-lymphocyte ratio, serum albumin, and estimated glomerular filtration rate.

Results: The QuantiFERON-TB Gold Plus® test was negative in 572 (80.3%) patients, positive in 106 (14.9%), and indeterminate in 34 (4.8%) cases. Positive results were significantly associated with a family history of confirmed and treated tuberculosis, OR (95% CI) = 52 (20.2-134.3). The use of immunosuppressive drugs and duration of treatment were significantly associated with the occurrence of indeterminate results: OR (95% CI) = 24.5 (5.8-103) and OR (95% CI) = 1.004 (1.002-1.007), respectively. Biologically, lymphopenia, hypoalbuminemia, and decreased estimated glomerular filtration rate were significant risk factors for indeterminate results: p = 5 E-6, p = 4.3 E-4, and p = 0.002, respectively. Thus, a multiple logistic regression model based on these three biological parameters enabled us to develop a predictive score for indeterminate results with a sensitivity of 91.2% and a specificity of 99.9%, AUC = 0.9964 (0.9917-1), p = 2.8 E-52.

Conclusion: Immunosuppressive therapy, lymphopenia, hypoalbuminemia, and kidney failure appeared to be risk factors for indeterminate QuantiFERON-TB Gold Plus® results.

背景:在开始抗肿瘤坏死因子(TNF)生物疗法或免疫抑制疗法之前,使用干扰素-γ释放测定法筛查潜伏结核感染是一项常规程序。目的:本横断面研究旨在估计突尼斯患者中定量FERON-TB Gold Plus®检测结果不确定的频率,并分析与这些不确定结果相关的潜在临床生物风险因素:采用 QuantiFERON-TB Gold Plus® 检测法对 712 名接受自身免疫性疾病监测的患者和抗肿瘤坏死因子生物疗法或免疫抑制疗法转换的候选者的全血样本进行潜伏结核感染筛查。根据文献背景,检测了以下变量与不确定结果的相关性:性别、年龄、糖尿病、免疫抑制剂、淋巴细胞计数、中性粒细胞与淋巴细胞比率、血清白蛋白和估计肾小球滤过率:572例(80.3%)患者的QuantiFERON-TB Gold Plus®检测结果为阴性,106例(14.9%)为阳性,34例(4.8%)为不确定。阳性结果与确诊和治疗过肺结核的家族史明显相关,OR (95% CI) = 52 (20.2-134.3)。使用免疫抑制剂和治疗持续时间与出现不确定结果有明显关系:OR (95% CI) = 24.5 (5.8-103) 和 OR (95% CI) = 1.004 (1.002-1.007)。从生物学角度看,淋巴细胞减少症、低白蛋白血症和估计肾小球滤过率降低是导致结果不确定的重要风险因素:分别为 p = 5 E-6、p = 4.3 E-4 和 p = 0.002。因此,基于这三个生物学参数的多元逻辑回归模型使我们能够建立一个预测不确定结果的评分,其灵敏度为 91.2%,特异性为 99.9%,AUC = 0.9964 (0.9917-1),p = 2.8 E-52:免疫抑制疗法、淋巴细胞减少症、低白蛋白血症和肾衰竭似乎是导致定量FERON-TB Gold Plus®检测结果不确定的风险因素。
{"title":"A regression predictive model for QuantiFERON-TB Gold Plus<sup>®</sup> indeterminate results in immunosuppressed patients.","authors":"Rahma Bellagha, Tarak Dhaouadi, Awatef Riahi, Wahiba Ben Rehouma, Hajer Jedidi, Leila Mouelhi, Leila Abdelmoula, Taïeb Ben Abdallah, Yousr Gorgi, Imen Sfar","doi":"10.1177/20503121241279116","DOIUrl":"https://doi.org/10.1177/20503121241279116","url":null,"abstract":"<p><strong>Background: </strong>Screening for latent tuberculosis infection using Interferon-Gamma Release Assays is a routine procedure prior to the initiation of anti-tumor necrosis factor (TNF) biotherapy or immunosuppressive therapy. However, indeterminate results are relatively frequent and are an obstacle to treatment initiation.</p><p><strong>Aim: </strong>The aim of this cross-sectional study was to estimate the frequency of indeterminate QuantiFERON-TB Gold Plus<sup>®</sup> test results in Tunisian patients, and to analyze the potential clinico-biological risk factors associated with these indeterminate results.</p><p><strong>Methods: </strong>Whole blood samples from 712 patients being monitored for autoimmune diseases and candidates for anti-TNF biotherapy or switch of immunosuppressive therapy were used to screen for latent tuberculosis infection using the QuantiFERON-TB Gold Plus<sup>®</sup> test. Based on literature background, the following variables were tested for the association with indeterminate results: gender, age, diabetes, immunosuppressive drugs, lymphocyte count, Neutrophil-to-lymphocyte ratio, serum albumin, and estimated glomerular filtration rate.</p><p><strong>Results: </strong>The QuantiFERON-TB Gold Plus<sup>®</sup> test was negative in 572 (80.3%) patients, positive in 106 (14.9%), and indeterminate in 34 (4.8%) cases. Positive results were significantly associated with a family history of confirmed and treated tuberculosis, OR (95% CI) = 52 (20.2-134.3). The use of immunosuppressive drugs and duration of treatment were significantly associated with the occurrence of indeterminate results: OR (95% CI) = 24.5 (5.8-103) and OR (95% CI) = 1.004 (1.002-1.007), respectively. Biologically, lymphopenia, hypoalbuminemia, and decreased estimated glomerular filtration rate were significant risk factors for indeterminate results: <i>p</i> = 5 E-6, <i>p</i> = 4.3 E-4, and <i>p</i> = 0.002, respectively. Thus, a multiple logistic regression model based on these three biological parameters enabled us to develop a predictive score for indeterminate results with a sensitivity of 91.2% and a specificity of 99.9%, AUC = 0.9964 (0.9917-1), <i>p</i> = 2.8 E-52.</p><p><strong>Conclusion: </strong>Immunosuppressive therapy, lymphopenia, hypoalbuminemia, and kidney failure appeared to be risk factors for indeterminate QuantiFERON-TB Gold Plus<sup>®</sup> results.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241279116"},"PeriodicalIF":2.3,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11388302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effectiveness of telemedicine in the management of type 2 diabetes: A systematic review. 远程医疗在 2 型糖尿病管理中的有效性:系统综述。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-09 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241271846
Truong Van Dat, Van Binh, Thai Minh Hoang, Vo Linh Tu, Pham Dinh Luyen, Le Thi Kim Anh

Background: Type 2 diabetes, a lifestyle-related disease demanding daily self-management, is a significant health concern. In this context, the use of telemedicine as a management tool is a relatively new and promising approach. This study aims to contribute to the growing body of knowledge by identifying the effectiveness of telemedicine in managing type 2 diabetes through a systematic review approach.

Methods: Four databases were searched including PubMed, Virtual Health Library, Global Health Library, and Google Scholar on 27 July 2022. Additionally, a manual search was performed to identify any relevant articles that may have been missed. The quality of the included articles was rigorously assessed using the Study Quality Assessment Tools of the National Institute of Health.

Results: We analyzed data from 134 articles. All 134 studies were published between 2002 and 2022, including 103 controlled intervention trials, 13 cohort studies, 7 before-after (pre-post) studies with no control group, 1 initial trial, 1 case study, 1 pilot study, and 8 two-arm studies that did not report the study design. Accordingly, most studies show positive changes in glycemic index in every group using telemedicine. Overall, although the BMI and weight indices in the studies improved at the end of the course, the improvement values were considered insignificant.

Conclusion: Telemedicine may be a valuable solution for blood sugar management in patients with type 2 diabetes. However, the effectiveness of telemedicine in improving BMI and quality of life is unclear.

背景:2 型糖尿病是一种与生活方式相关的疾病,需要日常自我管理,是一个重大的健康问题。在这种情况下,将远程医疗作为一种管理工具是一种相对较新且前景广阔的方法。本研究旨在通过系统综述的方法,确定远程医疗在管理 2 型糖尿病方面的有效性,从而为不断增长的知识库做出贡献:于 2022 年 7 月 27 日检索了四个数据库,包括 PubMed、虚拟健康图书馆、全球健康图书馆和谷歌学术。此外,还进行了人工检索,以确定可能遗漏的相关文章。我们使用美国国立卫生研究院的研究质量评估工具对收录文章的质量进行了严格评估:我们分析了 134 篇文章的数据。所有 134 项研究均发表于 2002 年至 2022 年之间,其中包括 103 项对照干预试验、13 项队列研究、7 项无对照组的前后(前-后)研究、1 项初步试验、1 项病例研究、1 项试点研究和 8 项未报告研究设计的双臂研究。因此,大多数研究显示,使用远程医疗的每个组的血糖指数都发生了积极变化。总体而言,虽然研究中的体重指数和体重指数在课程结束时有所改善,但改善值并不显著:结论:远程医疗可能是 2 型糖尿病患者血糖管理的重要解决方案。结论:远程医疗可能是 2 型糖尿病患者血糖管理的重要解决方案,但远程医疗在改善 BMI 和生活质量方面的效果尚不明确。
{"title":"The effectiveness of telemedicine in the management of type 2 diabetes: A systematic review.","authors":"Truong Van Dat, Van Binh, Thai Minh Hoang, Vo Linh Tu, Pham Dinh Luyen, Le Thi Kim Anh","doi":"10.1177/20503121241271846","DOIUrl":"https://doi.org/10.1177/20503121241271846","url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes, a lifestyle-related disease demanding daily self-management, is a significant health concern. In this context, the use of telemedicine as a management tool is a relatively new and promising approach. This study aims to contribute to the growing body of knowledge by identifying the effectiveness of telemedicine in managing type 2 diabetes through a systematic review approach.</p><p><strong>Methods: </strong>Four databases were searched including PubMed, Virtual Health Library, Global Health Library, and Google Scholar on 27 July 2022. Additionally, a manual search was performed to identify any relevant articles that may have been missed. The quality of the included articles was rigorously assessed using the Study Quality Assessment Tools of the National Institute of Health.</p><p><strong>Results: </strong>We analyzed data from 134 articles. All 134 studies were published between 2002 and 2022, including 103 controlled intervention trials, 13 cohort studies, 7 before-after (pre-post) studies with no control group, 1 initial trial, 1 case study, 1 pilot study, and 8 two-arm studies that did not report the study design. Accordingly, most studies show positive changes in glycemic index in every group using telemedicine. Overall, although the BMI and weight indices in the studies improved at the end of the course, the improvement values were considered insignificant.</p><p><strong>Conclusion: </strong>Telemedicine may be a valuable solution for blood sugar management in patients with type 2 diabetes. However, the effectiveness of telemedicine in improving BMI and quality of life is unclear.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241271846"},"PeriodicalIF":2.3,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11388326/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142294359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective effect of bone marrow mesenchymal stem cells on the survival zone of the perforator flaps in rats. 骨髓间充质干细胞对大鼠穿孔器皮瓣存活区的保护作用。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-06 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241276278
Fatemeh Bazgir, Arian Karimi Rouzbahani, Mehdi Birjandi, Farzaneh Chehelcheraghi

Background: Perforator flaps have recently been used in the field of plastic surgery. Skin defects can be reconstructed to reach functional and cosmetic goals. With the development of reconstructive approaches, utilizing stem cells is a hopeful approach to enhance wound healing and tissue recovery. In this study, we assessed the effect of bone marrow mesenchymal stem cells on the perforator flap's survival in rats.

Methods: Perforator flaps (2.5 × 11 cm) were transplanted into rats and focused on the thoracodorsal, intercostal, and deep circumflex arteries, which were randomly divided into three groups: control, saline, and bone marrow mesenchymal stem cells (7 × 106 ml). Seven days after the surgery, tissue edema, inflammation, and discharge were observed and photographed. Histological analyses were performed to determine flap survival. Hematoxylin and eosin staining was performed to assess levels of microvascular density determined in skin flaps.

Results: Rats in the bone marrow mesenchymal stem cells group exhibited higher average flap survival area, and higher microvascular density levels at the dynamical regions of the flaps compared with the other two groups. Subdermal injection of bone marrow mesenchymal stem cells significantly increased ischemic perforator flap survival due to stimulated neovascularization in rats.

Conclusion: Our findings suggest the potential usefulness of bone marrow mesenchymal stem cells in preventing skin flap perforator tissue necrosis.

背景:打孔器皮瓣最近被用于整形外科领域。皮肤缺损可通过重建达到功能和美容目的。随着重建方法的发展,利用干细胞来促进伤口愈合和组织恢复是一种充满希望的方法。在这项研究中,我们评估了骨髓间充质干细胞对大鼠穿孔皮瓣存活的影响:方法:将穿孔器皮瓣(2.5 × 11 厘米)移植到大鼠体内,并将其集中于胸背、肋间和深周动脉,随机分为三组:对照组、生理盐水组和骨髓间充质干细胞组(7 × 106 ml)。术后七天,对组织水肿、炎症和分泌物进行观察和拍照。进行组织学分析以确定皮瓣存活率。进行血红素和伊红染色以评估皮瓣中微血管密度的水平:结果:与其他两组相比,骨髓间充质干细胞组大鼠的皮瓣平均存活面积更高,皮瓣动态区域的微血管密度水平更高。骨髓间充质干细胞皮下注射可显著提高大鼠缺血穿孔皮瓣的存活率,这是因为骨髓间充质干细胞刺激了血管新生:我们的研究结果表明,骨髓间充质干细胞在预防皮瓣穿孔组织坏死方面具有潜在的作用。
{"title":"Protective effect of bone marrow mesenchymal stem cells on the survival zone of the perforator flaps in rats.","authors":"Fatemeh Bazgir, Arian Karimi Rouzbahani, Mehdi Birjandi, Farzaneh Chehelcheraghi","doi":"10.1177/20503121241276278","DOIUrl":"10.1177/20503121241276278","url":null,"abstract":"<p><strong>Background: </strong>Perforator flaps have recently been used in the field of plastic surgery. Skin defects can be reconstructed to reach functional and cosmetic goals. With the development of reconstructive approaches, utilizing stem cells is a hopeful approach to enhance wound healing and tissue recovery. In this study, we assessed the effect of bone marrow mesenchymal stem cells on the perforator flap's survival in rats.</p><p><strong>Methods: </strong>Perforator flaps (2.5 × 11 cm) were transplanted into rats and focused on the thoracodorsal, intercostal, and deep circumflex arteries, which were randomly divided into three groups: control, saline, and bone marrow mesenchymal stem cells (7 × 10<sup>6</sup> ml). Seven days after the surgery, tissue edema, inflammation, and discharge were observed and photographed. Histological analyses were performed to determine flap survival. Hematoxylin and eosin staining was performed to assess levels of microvascular density determined in skin flaps.</p><p><strong>Results: </strong>Rats in the bone marrow mesenchymal stem cells group exhibited higher average flap survival area, and higher microvascular density levels at the dynamical regions of the flaps compared with the other two groups. Subdermal injection of bone marrow mesenchymal stem cells significantly increased ischemic perforator flap survival due to stimulated neovascularization in rats.</p><p><strong>Conclusion: </strong>Our findings suggest the potential usefulness of bone marrow mesenchymal stem cells in preventing skin flap perforator tissue necrosis.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241276278"},"PeriodicalIF":2.3,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between the presence of Helicobacter pylori and the development of de novo anemia in adults undergoing sleeve gastrectomy. 接受袖状胃切除术的成人中幽门螺杆菌的存在与新生贫血的发生之间的关系。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-31 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241275340
Tammy S Carrillo-Levin, Maria F Jaramillo-Ocharan, Gustavo Salinas-Sedo, Carlos J Toro-Huamanchumo

Background: Sleeve gastrectomy has gained prominence in obesity treatment, yet it is not without complications, such as the development of anemia in the medium term. Given the high prevalence of Helicobacter pylori infection in Peru, it is imperative to explore its potential association with this postoperative complication.

Objective: To evaluate the association between the presence of Helicobacter pylori and the development of anemia 12 months after sleeve gastrectomy.

Methods: A retrospective cohort study was carried out based on an analysis of secondary data from a private clinic in Lima, Peru, which included two groups of people over 18 years of age who had undergone sleeve gastrectomy between 2010 and 2020. We considered the subjects who had the previous diagnosis of Helicobacter pylori as well as those who did not have the infection, according to the detection of the bacteria by endoscopy before surgery.

Results: A total 313 individuals were analyzed, and it was found that the prevalence of Helicobacter pylori was 46.0% and the incidence of anemia 12 months after sleeve gastrectomy was 18.2%. The presence of Helicobacter pylori increased the risk of de novo anemia (Relative Risk = 1.56; 95% confidence intervals: 1.02-2.41; p = 0.043). When stratifying by sex, the association was maintained only for the male group (Relative Risk = 2.84; 95% confidence intervals: 1.02-7.02; p = 0.047).

Conclusions: It was identified that the presence of Helicobacter pylori had a significant association with the development of de novo anemia, mainly in male subjects, 1 year after undergoing sleeve gastrectomy.

背景:袖带胃切除术在肥胖症治疗中的地位日益突出,但也并非没有并发症,如中期贫血。鉴于幽门螺杆菌感染在秘鲁的高发率,探讨其与这种术后并发症的潜在关联势在必行:目的:评估幽门螺杆菌的存在与袖状胃切除术后 12 个月出现贫血之间的关系:我们对秘鲁利马一家私人诊所的二手数据进行了分析,并在此基础上开展了一项回顾性队列研究,研究对象包括两组在 2010 年至 2020 年间接受过袖状胃切除术的 18 岁以上人群。根据手术前内镜检查发现幽门螺杆菌的情况,我们考虑了先前诊断出幽门螺杆菌感染的受试者和未感染幽门螺杆菌的受试者:共对 313 人进行了分析,结果发现幽门螺杆菌的感染率为 46.0%,袖状胃切除术后 12 个月贫血的发生率为 18.2%。幽门螺杆菌的存在增加了新发贫血的风险(相对风险 = 1.56;95% 置信区间:1.02-2.41;P = 0.043)。按性别分层时,只有男性组保持这种关联(相对风险 = 2.84;95% 置信区间:1.02-7.02;P = 0.047):结论:研究发现,幽门螺杆菌的存在与新发贫血的发生有显著关联,主要发生在接受袖带胃切除术一年后的男性受试者中。
{"title":"Association between the presence of <i>Helicobacter pylori</i> and the development of de novo anemia in adults undergoing sleeve gastrectomy.","authors":"Tammy S Carrillo-Levin, Maria F Jaramillo-Ocharan, Gustavo Salinas-Sedo, Carlos J Toro-Huamanchumo","doi":"10.1177/20503121241275340","DOIUrl":"10.1177/20503121241275340","url":null,"abstract":"<p><strong>Background: </strong>Sleeve gastrectomy has gained prominence in obesity treatment, yet it is not without complications, such as the development of anemia in the medium term. Given the high prevalence of <i>Helicobacter pylori</i> infection in Peru, it is imperative to explore its potential association with this postoperative complication.</p><p><strong>Objective: </strong>To evaluate the association between the presence of <i>Helicobacter pylori</i> and the development of anemia 12 months after sleeve gastrectomy.</p><p><strong>Methods: </strong>A retrospective cohort study was carried out based on an analysis of secondary data from a private clinic in Lima, Peru, which included two groups of people over 18 years of age who had undergone sleeve gastrectomy between 2010 and 2020. We considered the subjects who had the previous diagnosis of <i>Helicobacter pylori</i> as well as those who did not have the infection, according to the detection of the bacteria by endoscopy before surgery.</p><p><strong>Results: </strong>A total 313 individuals were analyzed, and it was found that the prevalence of <i>Helicobacter pylori</i> was 46.0% and the incidence of anemia 12 months after sleeve gastrectomy was 18.2%. The presence of <i>Helicobacter pylori</i> increased the risk of de novo anemia (Relative Risk = 1.56; 95% confidence intervals: 1.02-2.41; <i>p</i> = 0.043). When stratifying by sex, the association was maintained only for the male group (Relative Risk = 2.84; 95% confidence intervals: 1.02-7.02; <i>p</i> = 0.047).</p><p><strong>Conclusions: </strong>It was identified that the presence of <i>Helicobacter pylori</i> had a significant association with the development of de novo anemia, mainly in male subjects, 1 year after undergoing sleeve gastrectomy.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241275340"},"PeriodicalIF":2.3,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367693/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic review on factors influencing Middle Eastern women's utilization of healthcare services: The promise of mHealth. 中东妇女利用医疗保健服务的影响因素系统回顾:移动医疗的前景。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-31 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241276678
Mohsen Khosravi, Seyyed Morteza Mojtabaeian, Mina Aghamaleki Sarvestani

Objectives: The 2030 Sustainable Development Agenda stresses a feminist approach for healthcare services. Cultural and religious influences impact utilization of healthcare services by Muslim women within the Middle East, posing unique challenges. This paper aimed to investigate the factors influencing Middle Eastern women's utilization of healthcare services within the region.

Methods: In the year 2024, a systematic review was conducted. PubMed, Scopus, ProQuest, and the Cochrane Database of Systematic Reviews were searched for this purpose. The quality of the included articles was assessed using the Accuracy, Coverage, Objectivity, Date, Significance (ACODS) checklist. Subsequently, the Joffe method of thematic analysis was employed to analyze the data obtained from the review.

Results: A final selection comprising 59 studies was made for inclusion in the research. The studies demonstrated a high level of quality, and the risk of bias within them was deemed acceptable. The thematic analysis revealed seven principal themes, which encompassed Demographic Factors, Level of Education and Awareness, Sources of Information, Risk Factors, Personal Factors, Level of Service Access and Quality, and Organizational Factors.

Conclusions: This study highlighted key factors influencing women's utilization of healthcare in the Middle East and potentially the healthcare systems with a large number of Middle Eastern female immigrants around the globe: educational factors such as awareness campaigns and patient education, and personal barriers like fear and cultural norms. Moreover, Telehealth, particularly mHealth, was suggested to enhance women's participation and utilization of healthcare services. Further research is needed to explore this assertion with greater precision.

目标2030 年可持续发展议程强调在医疗保健服务中采用女权主义方法。文化和宗教影响影响着中东穆斯林妇女对医疗保健服务的利用,从而带来了独特的挑战。本文旨在调查影响中东地区妇女利用医疗保健服务的因素:在 2024 年进行了一次系统性回顾。为此检索了 PubMed、Scopus、ProQuest 和 Cochrane 系统综述数据库。采用准确性、覆盖面、客观性、日期、重要性(ACODS)核对表对收录文章的质量进行了评估。随后,采用乔菲主题分析法对综述中获得的数据进行了分析:结果:最终选定 59 项研究纳入研究范围。这些研究的质量较高,其中存在的偏倚风险被认为是可以接受的。专题分析揭示了七个主要专题,包括人口因素、教育和认识水平、信息来源、风险因素、个人因素、服务获取和质量水平以及组织因素:本研究强调了影响中东妇女利用医疗保健的关键因素,以及可能影响全球拥有大量中东女性移民的医疗保健系统的关键因素:教育因素(如宣传活动和患者教育)以及个人障碍(如恐惧和文化规范)。此外,远程保健,尤其是移动保健,被认为可以提高妇女对医疗保健服务的参与和利用。要更准确地探讨这一论断,还需要进一步的研究。
{"title":"A systematic review on factors influencing Middle Eastern women's utilization of healthcare services: The promise of mHealth.","authors":"Mohsen Khosravi, Seyyed Morteza Mojtabaeian, Mina Aghamaleki Sarvestani","doi":"10.1177/20503121241276678","DOIUrl":"10.1177/20503121241276678","url":null,"abstract":"<p><strong>Objectives: </strong>The 2030 Sustainable Development Agenda stresses a feminist approach for healthcare services. Cultural and religious influences impact utilization of healthcare services by Muslim women within the Middle East, posing unique challenges. This paper aimed to investigate the factors influencing Middle Eastern women's utilization of healthcare services within the region.</p><p><strong>Methods: </strong>In the year 2024, a systematic review was conducted. PubMed, Scopus, ProQuest, and the Cochrane Database of Systematic Reviews were searched for this purpose. The quality of the included articles was assessed using the Accuracy, Coverage, Objectivity, Date, Significance (ACODS) checklist. Subsequently, the Joffe method of thematic analysis was employed to analyze the data obtained from the review.</p><p><strong>Results: </strong>A final selection comprising 59 studies was made for inclusion in the research. The studies demonstrated a high level of quality, and the risk of bias within them was deemed acceptable. The thematic analysis revealed seven principal themes, which encompassed Demographic Factors, Level of Education and Awareness, Sources of Information, Risk Factors, Personal Factors, Level of Service Access and Quality, and Organizational Factors.</p><p><strong>Conclusions: </strong>This study highlighted key factors influencing women's utilization of healthcare in the Middle East and potentially the healthcare systems with a large number of Middle Eastern female immigrants around the globe: educational factors such as awareness campaigns and patient education, and personal barriers like fear and cultural norms. Moreover, Telehealth, particularly mHealth, was suggested to enhance women's participation and utilization of healthcare services. Further research is needed to explore this assertion with greater precision.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241276678"},"PeriodicalIF":2.3,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harmony unveiled: Intricate the interplay of dietary factor, gut microbiota, and colorectal cancer-A narrative review. 和谐揭幕:饮食因素、肠道微生物群与结直肠癌之间错综复杂的相互作用--叙述性综述。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-31 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241274724
Hiwot Tezera Endale, Winta Tesfaye, Fethiya Seid Hassen, Wastina Bitewlign Asrat, Elizabeth Yihune Temesgen, Yadelew Yimer Shibabaw, Tseganesh Asefa

Diet plays a critical role in shaping the gut microbiome, which in turn regulates molecular activities in the colonic mucosa. The state and composition of the gut microbiome are key factors in the development of colorectal cancer. An altered gut microbiome, linked to weakened immune responses and the production of carcinogenic substances, is a significant contributor to colorectal cancer pathogenesis. Dietary changes that involve low-fiber and phytomolecule intake, coupled with higher consumption of red meat, can raise the risk of colorectal cancer. Salutary filaments, which reach the colon undigested, are metabolized by the gut microbiome, producing short-chain fatty acids. Short-chain fatty acids possess beneficial anti-inflammatory and antiproliferative properties that promote colon health. A well-balanced microbiome, supported by beneficial fibers and phytochemicals, can regulate the activation of proto-oncogenes and oncogenic pathways, thereby reducing cell proliferation. Recent research suggests that an overabundance of specific microbes, such as Fusobacterium nucleatum, may contribute to adverse changes in the colonic mucosa. Positive lifestyle adjustments have been demonstrated to effectively inhibit the growth of harmful opportunistic organisms. Synbiotics, which combine probiotics and prebiotics, can protect the intestinal mucosa by enhancing immune responses and decreasing the production of harmful metabolites, oxidative stress, and cell proliferation. This narrative review provides a concise understanding of evolving evidence regarding how diet influences the gut microbiome, leading to the restoration of the colonic epithelium. It underscores the importance of a healthy, plant-based diet and associated supplements in preventing colorectal cancer by enhancing gut microbiome health.

饮食在塑造肠道微生物群方面起着至关重要的作用,而肠道微生物群又反过来调节结肠粘膜的分子活动。肠道微生物群的状态和组成是结直肠癌发病的关键因素。肠道微生物群的改变与免疫反应减弱和致癌物质的产生有关,是导致结直肠癌发病的重要因素。低纤维和植物大分子摄入量的饮食变化,加上红肉摄入量的增加,会增加罹患结直肠癌的风险。未经消化进入结肠的膳食纤维会被肠道微生物群代谢,产生短链脂肪酸。短链脂肪酸具有有益的抗炎和抗增生特性,可促进结肠健康。在有益纤维和植物化学物质的支持下,平衡的微生物群可以调节原癌基因和致癌途径的活化,从而减少细胞增殖。最新研究表明,特定微生物(如核酸镰刀菌)的过度繁殖可能会导致结肠粘膜发生不良变化。事实证明,积极调整生活方式能有效抑制有害机会性微生物的生长。益生菌和益生元相结合的复合益生菌可通过增强免疫反应、减少有害代谢物的产生、氧化应激和细胞增殖来保护肠粘膜。本综述简要介绍了有关饮食如何影响肠道微生物组并导致结肠上皮恢复的证据。它强调了以植物为基础的健康饮食和相关补充剂通过增强肠道微生物组健康来预防结直肠癌的重要性。
{"title":"Harmony unveiled: Intricate the interplay of dietary factor, gut microbiota, and colorectal cancer-A narrative review.","authors":"Hiwot Tezera Endale, Winta Tesfaye, Fethiya Seid Hassen, Wastina Bitewlign Asrat, Elizabeth Yihune Temesgen, Yadelew Yimer Shibabaw, Tseganesh Asefa","doi":"10.1177/20503121241274724","DOIUrl":"10.1177/20503121241274724","url":null,"abstract":"<p><p>Diet plays a critical role in shaping the gut microbiome, which in turn regulates molecular activities in the colonic mucosa. The state and composition of the gut microbiome are key factors in the development of colorectal cancer. An altered gut microbiome, linked to weakened immune responses and the production of carcinogenic substances, is a significant contributor to colorectal cancer pathogenesis. Dietary changes that involve low-fiber and phytomolecule intake, coupled with higher consumption of red meat, can raise the risk of colorectal cancer. Salutary filaments, which reach the colon undigested, are metabolized by the gut microbiome, producing short-chain fatty acids. Short-chain fatty acids possess beneficial anti-inflammatory and antiproliferative properties that promote colon health. A well-balanced microbiome, supported by beneficial fibers and phytochemicals, can regulate the activation of proto-oncogenes and oncogenic pathways, thereby reducing cell proliferation. Recent research suggests that an overabundance of specific microbes, such as <i>Fusobacterium nucleatum</i>, may contribute to adverse changes in the colonic mucosa. Positive lifestyle adjustments have been demonstrated to effectively inhibit the growth of harmful opportunistic organisms. Synbiotics, which combine probiotics and prebiotics, can protect the intestinal mucosa by enhancing immune responses and decreasing the production of harmful metabolites, oxidative stress, and cell proliferation. This narrative review provides a concise understanding of evolving evidence regarding how diet influences the gut microbiome, leading to the restoration of the colonic epithelium. It underscores the importance of a healthy, plant-based diet and associated supplements in preventing colorectal cancer by enhancing gut microbiome health.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241274724"},"PeriodicalIF":2.3,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The presence of animals in hospital facilities: A preliminary study on the opinion of doctors, healthcare workers, and students in Sardinia. 动物在医院设施中的存在:关于撒丁岛医生、医护人员和学生意见的初步研究。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-31 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241275230
Eraldo Sanna Passino, Sara Sechi, Alessandra Mollica, Fabrizio Demaria, Raffaella Cocco

Introduction: Contact with pets within healthcare settings is considered worldwide an added value to assistance both in the case of animal-assisted interventions and also when pets are visiting hospitalized owners, due to the special emotional relationship between them and their pets. The goal of this work was to analyze local experiences on access of pets to healthcare facilities using a survey sent to doctors, veterinarians, and students in the region of Sardinia (Italy).

Methods: The online survey consisted of 17 questions, with the objective to evaluate knowledge and interest of study participants on some aspects of human-animal interaction with particular reference to potential access of pets to hospitals facilities and nursing homes and to promote an initial social judgment in the medical and healthcare environment. A total of 2484 subjects were invited to participate to the survey through an email explaining the purpose of the study. Statistical analysis on the survey results was conducted by comparing the characteristics of respondents with their answers to animal-assisted-intervention-related questions.

Results: Results showed that over 70% of the participants owned an animal; almost 80% of responses showed that survey participants were in favor of animal presence in hospitals; furthermore, the responses showed how the concept of One Health seems not only scarcely established, but also barely known. The large majority of respondents (over 80%) positively responded on questions around the role of animals as co-therapists.

Conclusions: On the one hand, this study showed lack of knowledge on the concept of One Health, whose essence is too often unknown and, on the other hand, it confirmed that women may be more inclined to show empathy and sensitivity toward animals. Regarding the profession, students seem more concerned about the introduction of animals into hospitals than healthcare workers.

导言:在世界范围内,与宠物在医疗机构中的接触被认为是一种额外的援助价值,无论是在动物辅助干预的情况下,还是在宠物探望住院的主人时,都是如此,因为主人与宠物之间有着特殊的情感关系。这项工作的目的是通过向撒丁岛(意大利)地区的医生、兽医和学生发送调查问卷,分析当地在宠物进入医疗机构方面的经验:在线调查包括 17 个问题,目的是评估研究参与者对人与动物互动某些方面的知识和兴趣,尤其是宠物可能进入医院设施和疗养院的情况,并促进对医疗保健环境的初步社会判断。研究人员通过电子邮件向 2484 名受试者解释了研究目的,并邀请他们参与调查。通过比较受访者的特征及其对动物辅助干预相关问题的回答,对调查结果进行了统计分析:结果显示,超过 70% 的参与者拥有动物;近 80% 的回答显示,调查参与者赞成动物在医院中的存在;此外,回答还显示,"一体健康 "的概念似乎不仅尚未确立,而且也鲜为人知。绝大多数受访者(超过 80%)都对动物作为合作治疗师的作用做出了积极回应:一方面,这项研究表明,人们对 "一体健康 "概念缺乏了解,其本质往往不为人知;另一方面,研究证实,女性可能更倾向于对动物表现出同情和敏感。在职业方面,学生似乎比医护人员更关心将动物引入医院的问题。
{"title":"The presence of animals in hospital facilities: A preliminary study on the opinion of doctors, healthcare workers, and students in Sardinia.","authors":"Eraldo Sanna Passino, Sara Sechi, Alessandra Mollica, Fabrizio Demaria, Raffaella Cocco","doi":"10.1177/20503121241275230","DOIUrl":"10.1177/20503121241275230","url":null,"abstract":"<p><strong>Introduction: </strong>Contact with pets within healthcare settings is considered worldwide an added value to assistance both in the case of animal-assisted interventions and also when pets are visiting hospitalized owners, due to the special emotional relationship between them and their pets. The goal of this work was to analyze local experiences on access of pets to healthcare facilities using a survey sent to doctors, veterinarians, and students in the region of Sardinia (Italy).</p><p><strong>Methods: </strong>The online survey consisted of 17 questions, with the objective to evaluate knowledge and interest of study participants on some aspects of human-animal interaction with particular reference to potential access of pets to hospitals facilities and nursing homes and to promote an initial social judgment in the medical and healthcare environment. A total of 2484 subjects were invited to participate to the survey through an email explaining the purpose of the study. Statistical analysis on the survey results was conducted by comparing the characteristics of respondents with their answers to animal-assisted-intervention-related questions.</p><p><strong>Results: </strong>Results showed that over 70% of the participants owned an animal; almost 80% of responses showed that survey participants were in favor of animal presence in hospitals; furthermore, the responses showed how the concept of One Health seems not only scarcely established, but also barely known. The large majority of respondents (over 80%) positively responded on questions around the role of animals as co-therapists.</p><p><strong>Conclusions: </strong>On the one hand, this study showed lack of knowledge on the concept of One Health, whose essence is too often unknown and, on the other hand, it confirmed that women may be more inclined to show empathy and sensitivity toward animals. Regarding the profession, students seem more concerned about the introduction of animals into hospitals than healthcare workers.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241275230"},"PeriodicalIF":2.3,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367599/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 vaccine-associated vasculitis: A systematic review. COVID-19 疫苗相关性血管炎:系统综述。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241261165
Aseel Abuhammad, Maram Albandak, Mohammed Ayyad, Eman Refayeh, Basema Qawasma, Shaima Hour, Yazan Abu Thraiee, Zaid A Sowaity, Osama Dukmak, Afnan W M Jobran, Laith Alamleh

Objectives: Post-COVID-19 vaccine-associated vasculitis stands as one of the most serious side effects attributed to COVID-19 vaccines. This complication encompasses diverse manifestations which vary in presentation and severity. Moreover, it can impact patients across all age groups, with a notably elevated incidence in the elderly. This systematic review seeks to review and evaluate the spectrum of vasculitis manifestations linked to COVID-19 vaccination.

Methods: A systematic review of the literature was done by searching through PubMed, Google Scholar, and Scopus up to October 2022. Articles including data about sex, age at diagnosis, vasculitis clinical manifestations, type of vaccination, most commonly used investigations, comorbid medical conditions, treatments, and clinical outcomes were included in the final analysis. Furthermore, vasculitis flare-ups post-vaccination were considered part of this review.

Results: A total number of 117 studies describing 158 patients developing vasculitis following COVID-19 vaccination were included in the final analysis. Among the patients who developed vasculitis, the most administered type of vaccination was the mRNA vaccine subtype (n = 103), followed by the viral vector vaccines (n = 42) and inactivated viral vaccines (n = 10). On the other hand, about 38% of vasculitis-related symptoms occurred after the administration of the first dose of the vaccine and 37% occurred after taking the second dose. The skin (60.7%) and the kidneys (27.8%) were the most affected organs and complete remission was achieved in 111 patients (70%), while partial remission occurred in 11% of the patient population.

Conclusion: COVID-19 vaccine-induced vasculitis is a rare occurrence associated with COVID-19 vaccines. It generally presents a favorable prognosis and outcomes for the vast majority of patients, ultimately leading to full remission within days. This review emphasizes the notion that the advantages of COVID-19 vaccines outweigh the potential risks, particularly for individuals with compromised immune systems.

目标:COVID-19 疫苗接种后相关血管炎是 COVID-19 疫苗最严重的副作用之一。这种并发症包括多种表现形式,其表现形式和严重程度各不相同。此外,它可影响所有年龄组的患者,尤其是老年人的发病率较高。本系统综述旨在回顾和评估与接种 COVID-19 疫苗相关的血管炎表现:通过搜索 PubMed、Google Scholar 和 Scopus,对截至 2022 年 10 月的文献进行了系统综述。最终分析纳入的文章包括性别、诊断年龄、血管炎临床表现、疫苗接种类型、最常用的检查方法、合并症、治疗方法和临床结果等数据。此外,接种疫苗后脉管炎复发也被视为本次综述的一部分:结果:共有 117 项研究纳入了最终分析,这些研究描述了 158 名接种 COVID-19 疫苗后出现血管炎的患者。在发生血管炎的患者中,接种最多的疫苗类型是 mRNA 疫苗亚型(103 例),其次是病毒载体疫苗(42 例)和灭活病毒疫苗(10 例)。另一方面,约 38% 的血管炎相关症状发生在接种第一剂疫苗后,37% 发生在接种第二剂疫苗后。皮肤(60.7%)和肾脏(27.8%)是受影响最严重的器官,111名患者(70%)的病情完全缓解,11%的患者病情部分缓解:结论:COVID-19疫苗诱发的血管炎是一种与COVID-19疫苗相关的罕见病。结论:COVID-19 疫苗诱发的血管炎是与 COVID-19 疫苗相关的罕见病症,一般来说,绝大多数患者的预后和治疗效果良好,最终可在数天内完全缓解。本综述强调 COVID-19 疫苗的优势大于潜在风险,尤其是对于免疫系统受损的患者。
{"title":"COVID-19 vaccine-associated vasculitis: A systematic review.","authors":"Aseel Abuhammad, Maram Albandak, Mohammed Ayyad, Eman Refayeh, Basema Qawasma, Shaima Hour, Yazan Abu Thraiee, Zaid A Sowaity, Osama Dukmak, Afnan W M Jobran, Laith Alamleh","doi":"10.1177/20503121241261165","DOIUrl":"10.1177/20503121241261165","url":null,"abstract":"<p><strong>Objectives: </strong>Post-COVID-19 vaccine-associated vasculitis stands as one of the most serious side effects attributed to COVID-19 vaccines. This complication encompasses diverse manifestations which vary in presentation and severity. Moreover, it can impact patients across all age groups, with a notably elevated incidence in the elderly. This systematic review seeks to review and evaluate the spectrum of vasculitis manifestations linked to COVID-19 vaccination.</p><p><strong>Methods: </strong>A systematic review of the literature was done by searching through PubMed, Google Scholar, and Scopus up to October 2022. Articles including data about sex, age at diagnosis, vasculitis clinical manifestations, type of vaccination, most commonly used investigations, comorbid medical conditions, treatments, and clinical outcomes were included in the final analysis. Furthermore, vasculitis flare-ups post-vaccination were considered part of this review.</p><p><strong>Results: </strong>A total number of 117 studies describing 158 patients developing vasculitis following COVID-19 vaccination were included in the final analysis. Among the patients who developed vasculitis, the most administered type of vaccination was the mRNA vaccine subtype (<i>n</i> = 103), followed by the viral vector vaccines (<i>n</i> = 42) and inactivated viral vaccines (<i>n</i> = 10). On the other hand, about 38% of vasculitis-related symptoms occurred after the administration of the first dose of the vaccine and 37% occurred after taking the second dose. The skin (60.7%) and the kidneys (27.8%) were the most affected organs and complete remission was achieved in 111 patients (70%), while partial remission occurred in 11% of the patient population.</p><p><strong>Conclusion: </strong>COVID-19 vaccine-induced vasculitis is a rare occurrence associated with COVID-19 vaccines. It generally presents a favorable prognosis and outcomes for the vast majority of patients, ultimately leading to full remission within days. This review emphasizes the notion that the advantages of COVID-19 vaccines outweigh the potential risks, particularly for individuals with compromised immune systems.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241261165"},"PeriodicalIF":2.3,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367607/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heartware ventricular assist device versus HeartMate II versus HeartMate III in advanced heart failure patients: A systematic review and meta-analysis. 在晚期心力衰竭患者中,Heartware 心室辅助装置与 HeartMate II 和 HeartMate III 的比较:系统回顾和荟萃分析。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241278226
Dudy Arman Hanafy, Theresia Feline Husen, Ruth Angelica, Ilona Nathania, Widya Trianita Suwatri, Pasati Lintangella, Wahyu Prima Erdianto, Prisillia Prasetyo

Objective: Ventricular assist device is one of the treatment options for heart failure patients. Therefore, the purpose of this review is to aid in clinical decision-making of exchanging previous older ventricular assist device models to the newest one, HM3.

Methods: The search was conducted across several databases until February 25, 2023, and was registered with the ID of CRD42023405367. Risk of bias was performed using Cochrane Risk of Bias 2.0 and the Newcastle Ottawa Scale. In order to rank and evaluate the pooled odds ratios and mean differences with 95% confidence intervals, we employed conventional and Bayesian network meta-analysis converted to surface under the cumulative ranking.

Results: A total of 49 studies with 31,105 patients were included in this review. HM3 is the best device exchange choice that causes the lowest risk of mortality (HM3 (99.98) > HM2 (32.43) > HVAD (17.58)), cerebrovascular accidents (HM3 (99.99) > HM2 (42.41) > HVAD (7.60)), other neurologic events beside cerebrovascular accident (HM3 (91.45) > HM2 (54.16) > HVAD (4.39)), pump thrombosis (HM3 (100.00) > HM2 (39.20) > HVAD (10.80)), and bleeding (HM3 (97.12) > HM2 (47.60) > HVAD (5.28)). HM3 is also better than HM2 in hospital admissions (OR: 1.90 (95% CI: 1.15-3.12)). When complications were present, HM2 or Heartware ventricular assist devices exchange to HM3 lowered the mortality rate compared to exchanging it to the same device type.

Conclusion: HM3 is the best device for all six outcomes. Exchange from Heartware ventricular assist devices or HM2 to HM3 rather than the same ventricular assist device type is recommended only if a complication is present.

目的:心室辅助装置是心衰患者的治疗选择之一。因此,本综述旨在帮助临床决定是否将以前的旧型心室辅助装置更换为最新型的 HM3:在 2023 年 2 月 25 日之前,在多个数据库中进行了检索,注册 ID 为 CRD42023405367。使用 Cochrane Risk of Bias 2.0 和纽卡斯尔-渥太华量表进行偏倚风险分析。为了对汇集的几率比和均值差异及95%置信区间进行排序和评估,我们采用了传统的贝叶斯网络荟萃分析法,并将其转换为累积排序下的表面分析法:本综述共纳入了 49 项研究,31105 名患者。HM3 是最佳的设备交换选择,其导致的死亡率(HM3(99.98)> HM2(32.43)> HVAD(17.58))、脑血管意外(HM3(99.99)> HM2(42.41)> HVAD(7.60))、脑血管意外以外的其他神经事件(HM3(91.45)> HM2(54.16)> HVAD(4.39))、泵血栓(HM3(100.00)> HM2(39.20)> HVAD(10.80))和出血(HM3(97.12)> HM2(47.60)> HVAD(5.28))。在入院率方面,HM3 也优于 HM2(OR:1.90(95% CI:1.15-3.12))。当出现并发症时,将HM2或Heartware心室辅助装置更换为HM3与更换为相同类型的装置相比,死亡率更低:结论:就所有六种结果而言,HM3 是最佳设备。只有在出现并发症时,才建议将 Heartware 心室辅助装置或 HM2 换成 HM3,而不是换成相同类型的心室辅助装置。
{"title":"Heartware ventricular assist device versus HeartMate II versus HeartMate III in advanced heart failure patients: A systematic review and meta-analysis.","authors":"Dudy Arman Hanafy, Theresia Feline Husen, Ruth Angelica, Ilona Nathania, Widya Trianita Suwatri, Pasati Lintangella, Wahyu Prima Erdianto, Prisillia Prasetyo","doi":"10.1177/20503121241278226","DOIUrl":"10.1177/20503121241278226","url":null,"abstract":"<p><strong>Objective: </strong>Ventricular assist device is one of the treatment options for heart failure patients. Therefore, the purpose of this review is to aid in clinical decision-making of exchanging previous older ventricular assist device models to the newest one, HM3.</p><p><strong>Methods: </strong>The search was conducted across several databases until February 25, 2023, and was registered with the ID of CRD42023405367. Risk of bias was performed using Cochrane Risk of Bias 2.0 and the Newcastle Ottawa Scale. In order to rank and evaluate the pooled odds ratios and mean differences with 95% confidence intervals, we employed conventional and Bayesian network meta-analysis converted to surface under the cumulative ranking.</p><p><strong>Results: </strong>A total of 49 studies with 31,105 patients were included in this review. HM3 is the best device exchange choice that causes the lowest risk of mortality (HM3 (99.98) > HM2 (32.43) > HVAD (17.58)), cerebrovascular accidents (HM3 (99.99) > HM2 (42.41) > HVAD (7.60)), other neurologic events beside cerebrovascular accident (HM3 (91.45) > HM2 (54.16) > HVAD (4.39)), pump thrombosis (HM3 (100.00) > HM2 (39.20) > HVAD (10.80)), and bleeding (HM3 (97.12) > HM2 (47.60) > HVAD (5.28)). HM3 is also better than HM2 in hospital admissions (OR: 1.90 (95% CI: 1.15-3.12)). When complications were present, HM2 or Heartware ventricular assist devices exchange to HM3 lowered the mortality rate compared to exchanging it to the same device type.</p><p><strong>Conclusion: </strong>HM3 is the best device for all six outcomes. Exchange from Heartware ventricular assist devices or HM2 to HM3 rather than the same ventricular assist device type is recommended only if a complication is present.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241278226"},"PeriodicalIF":2.3,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medicare skilled nursing facilities' occupancy and payer source: The moderating role of financial performance. 医疗保险专业护理机构的入住率与付款人来源:财务业绩的调节作用。
IF 2.3 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-08-30 eCollection Date: 2024-01-01 DOI: 10.1177/20503121241275368
Hyunmin Kim, Asos Mahmood, Cyril F Chang, Aram Dobalian

Objectives: While extensive research has focused on patient outcomes in skilled nursing facilities, a critical gap remains in understanding factors influencing their managerial performance, particularly occupancy rates. This study examines the occupancy rates of skilled nursing facilities and assesses the significance of two important drivers of managerial performance that have not received sufficient attention-the influence of payer mix and total profit margin. Specifically, we focused on the role played by a nursing home's financial performance (as assessed by profit margin) in influencing the relationship between payer mix and occupancy rate among skilled nursing facilities.

Methods: Data were extracted from the 2019 to 2020 Joint Annual Report of Nursing Homes for a sample of 612 skilled nursing facilities in Tennessee, USA. Regression analysis was performed by fitting a generalized estimating equation of occupancy rate.

Results: Compared to skilled nursing facilities in the lowest quartile of profit margin, for example, those in the highest quartile had approximately 18 percentage points higher occupancy rates per unit increase in resident days of care covered by traditional Medicare (β = 0.18, p = 0.0028). Similarly, skilled nursing facilities in the second highest quartile of profit margin had a higher occupancy rate by approximately 23 percentage points per unit increase in Medicare Advantage (β = 0.23, p = 0.0375) when compared to those in the lowest quartile of profit margin.

Conclusions: Skilled nursing facilities with stronger financial performance generally have higher occupancy rates, particularly notable in relation to an upswing in payer sources such as traditional Medicare and Medicare Advantage, when compared to skilled nursing facilities with weaker profitability. Given the increasingly larger role of Medicare in long-term care funding, policymakers and nursing home managers may find it useful to consider our findings when evaluating opportunities to enhance managerial performance of skilled nursing facilities.

目标:虽然对专业护理机构的患者治疗效果进行了广泛的研究,但在了解影响其管理绩效的因素(尤其是入住率)方面仍存在重大差距。本研究考察了专业护理机构的入住率,并评估了尚未引起足够重视的管理绩效的两个重要驱动因素--支付方组合和总利润率的影响。具体来说,我们重点研究了疗养院的财务绩效(以利润率评估)在影响支付方组合与专业护理机构入住率之间关系方面所发挥的作用:从美国田纳西州 612 家专业护理机构的《2019 至 2020 年养老院联合年度报告》中提取数据。通过拟合入住率的广义估计方程进行回归分析:例如,与利润率处于最低四分位数的专业护理机构相比,处于最高四分位数的专业护理机构的入住率比传统医疗保险覆盖的居民护理天数每增加一个单位高出约 18 个百分点(β = 0.18,p = 0.0028)。同样,与利润率处于最低四分位数的机构相比,利润率处于第二高四分位数的专业护理机构的入住率要高出约 23 个百分点(β = 0.23,p = 0.0375):与盈利能力较弱的专业护理机构相比,财务状况较好的专业护理机构一般具有较高的入住率,尤其是在传统医疗保险和医疗保险优势等支付来源上升的情况下。鉴于医疗保险在长期护理资金中扮演着越来越重要的角色,政策制定者和疗养院管理者在评估提高专业护理机构管理绩效的机会时,不妨考虑一下我们的研究结果。
{"title":"Medicare skilled nursing facilities' occupancy and payer source: The moderating role of financial performance.","authors":"Hyunmin Kim, Asos Mahmood, Cyril F Chang, Aram Dobalian","doi":"10.1177/20503121241275368","DOIUrl":"10.1177/20503121241275368","url":null,"abstract":"<p><strong>Objectives: </strong>While extensive research has focused on patient outcomes in skilled nursing facilities, a critical gap remains in understanding factors influencing their managerial performance, particularly occupancy rates. This study examines the occupancy rates of skilled nursing facilities and assesses the significance of two important drivers of managerial performance that have not received sufficient attention-the influence of payer mix and total profit margin. Specifically, we focused on the role played by a nursing home's financial performance (as assessed by profit margin) in influencing the relationship between payer mix and occupancy rate among skilled nursing facilities.</p><p><strong>Methods: </strong>Data were extracted from the 2019 to 2020 Joint Annual Report of Nursing Homes for a sample of 612 skilled nursing facilities in Tennessee, USA. Regression analysis was performed by fitting a generalized estimating equation of occupancy rate.</p><p><strong>Results: </strong>Compared to skilled nursing facilities in the lowest quartile of profit margin, for example, those in the highest quartile had approximately 18 percentage points higher occupancy rates per unit increase in resident days of care covered by traditional Medicare (β = 0.18, <i>p</i> = 0.0028). Similarly, skilled nursing facilities in the second highest quartile of profit margin had a higher occupancy rate by approximately 23 percentage points per unit increase in Medicare Advantage (β = 0.23, <i>p</i> = 0.0375) when compared to those in the lowest quartile of profit margin.</p><p><strong>Conclusions: </strong>Skilled nursing facilities with stronger financial performance generally have higher occupancy rates, particularly notable in relation to an upswing in payer sources such as traditional Medicare and Medicare Advantage, when compared to skilled nursing facilities with weaker profitability. Given the increasingly larger role of Medicare in long-term care funding, policymakers and nursing home managers may find it useful to consider our findings when evaluating opportunities to enhance managerial performance of skilled nursing facilities.</p>","PeriodicalId":21398,"journal":{"name":"SAGE Open Medicine","volume":"12 ","pages":"20503121241275368"},"PeriodicalIF":2.3,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367703/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142120534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
SAGE Open Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1